000 01183 a2200349 4500
005 20250511230802.0
264 0 _c19901205
008 199012s 0 0 eng d
022 _a0300-0664
024 7 _a10.1111/j.1365-2265.1990.tb00494.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRoelfsema, F
245 0 0 _aThe influence of octreotide treatment on pulsatile growth hormone release in acromegaly.
_h[electronic resource]
260 _bClinical endocrinology
_cAug 1990
300 _a297-306 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAcromegaly
_xblood
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aCircadian Rhythm
_xphysiology
650 0 4 _aFemale
650 0 4 _aGrowth Hormone
_xblood
650 0 4 _aHumans
650 0 4 _aInsulin-Like Growth Factor I
_xanalysis
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aOctreotide
_xtherapeutic use
700 1 _ade Boer, H
700 1 _aFrölich, M
773 0 _tClinical endocrinology
_gvol. 33
_gno. 2
_gp. 297-306
856 4 0 _uhttps://doi.org/10.1111/j.1365-2265.1990.tb00494.x
_zAvailable from publisher's website
999 _c2231607
_d2231607